…
Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The company offers financial and operational performance improvement consulting services; digital services; spanning technology and analytic-related services, including enterprise health record, enterprise resource planning, enterprise performance management, customer relationship management, data management, artificial intelligence and automation, technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. It also provides research-focused consulting and managed services, as well as Huron Research product suite, a software suite designed to facilitate and improve research administration service delivery and compliance. In addition, the company offers software products, financial capital advisory services, regulatory compliance and risk management consulting, and Commercial consulting. The company serves healthcare, education, financial services, industrials and manufacturing, energy and utilities, public sector, and other commercial industries. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Huron Consulting Group provides advisory and technology-enabled services to healthcare, life sciences, higher education and commercial clients focused on operational improvement, compliance and transaction support. Long-term growth may be supported by digital transformation, regulatory complexity and demand for cost-efficiency, and the company appears positioned to benefit from diversified end markets and recurring client relationships.
Key risks include cyclicality and timing of client spending, intense competition for projects and talent, and exposure to regulatory and reimbursement changes in healthcare that could affect demand.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 135.08M | 154.02M | 83.89M | 108.58M | 80.04M |
| Net income | 105.04M | 116.63M | 62.48M | 75.55M | 62.99M |
| Selling general administrative | 318.01M | 273.59M | 246.28M | 209.38M | 177.89M |
| Selling and marketing expenses | - | 10.20M | 7.30M | - | - |
| Gross profit | 508.79M | 476.01M | 419.36M | 346.41M | 268.81M |
| Reconciled depreciation | 32.43M | 25.30M | 25.43M | 27.36M | 25.98M |
| Ebit | 169.28M | 166.59M | 141.25M | 99.76M | 78.04M |
| Ebitda | 201.71M | 184.29M | 159.69M | 146.94M | 104.02M |
| Depreciation and amortization | 32.43M | 17.70M | 18.44M | 47.18M | 25.98M |
| Operating income | 199.30M | 168.82M | 125.35M | 99.76M | 78.04M |
| Other operating expenses | 1499.84M | 1317.27M | 1236.71M | 1049.29M | 861.52M |
| Interest expense | 34.20M | 25.35M | 19.57M | -11.88M | -8.15M |
| Tax provision | 30.04M | 37.39M | 28.77M | 33.02M | 17.05M |
| Net interest income | -34.20M | -25.35M | -19.28M | -11.88M | -8.15M |
| Income tax expense | 30.04M | 37.39M | 21.42M | 33.02M | 17.05M |
| Total revenue | 1699.14M | 1486.09M | 1362.06M | 1158.96M | 926.96M |
| Total operating expenses | 309.49M | 307.19M | 294.01M | 236.74M | 203.38M |
| Cost of revenue | 1190.35M | 1010.08M | 942.70M | 812.55M | 658.14M |
| Total other income expense net | -64.22M | -14.80M | -41.45M | 8.82M | 2.00M |
| Net income from continuing ops | 105.04M | 116.63M | 76.73M | 75.55M | 62.99M |
| Net income applicable to common shares | - | - | - | 75.55M | 62.99M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1526.68M | 1343.62M | 1262.14M | 1199.04M | 1119.35M |
| Intangible assets | 72.93M | 87.18M | 18.07M | 23.39M | 31.89M |
| Other current assets | 33.68M | 28.06M | 28.49M | 26.06M | 15.23M |
| Total liab | 998.05M | 782.29M | 729.25M | 647.00M | 547.45M |
| Total stockholder equity | 528.63M | 561.33M | 532.89M | 552.04M | 571.90M |
| Deferred long term liab | - | - | - | - | 55.73M |
| Other current liab | 305.07M | 274.35M | 259.01M | 198.99M | 161.65M |
| Common stock | 0.20M | 0.21M | 0.21M | 0.22M | 0.24M |
| Capital stock | 0.20M | 0.21M | 0.21M | 0.22M | 0.24M |
| Retained earnings | 636.69M | 531.65M | 415.03M | 352.55M | 277.00M |
| Other liab | - | - | - | 65.76M | 55.73M |
| Good will | 786.90M | 678.74M | 625.71M | 624.97M | 620.88M |
| Other assets | - | - | - | 43.26M | 70.00M |
| Cash | 24.51M | 21.91M | 12.15M | 11.83M | 20.78M |
| Total current liabilities | 383.43M | 338.82M | 302.57M | 245.68M | 205.18M |
| Current deferred revenue | 31.71M | 26.87M | 22.46M | 21.91M | 19.21M |
| Net debt | 523.83M | 376.70M | 361.73M | 334.25M | 276.45M |
| Short term debt | 34.30M | 26.07M | 11.03M | 10.53M | 10.70M |
| Short long term debt | 20.00M | 13.75M | - | - | 0.56M |
| Short long term debt total | 548.34M | 398.61M | 373.88M | 346.09M | 297.24M |
| Other stockholder equity | -102.10M | 17.58M | 94.83M | 181.15M | 277.82M |
| Property plant equipment | - | - | - | 56.41M | 31.00M |
| Total current assets | 448.58M | 409.12M | 400.46M | 328.48M | 257.68M |
| Long term investments | 36.43M | 69.71M | 75.41M | 91.19M | 72.58M |
| Net tangible assets | - | - | - | -122.52M | -80.87M |
| Short term investments | - | - | 6.66M | - | - |
| Net receivables | 390.40M | 359.14M | 359.82M | 290.59M | 221.67M |
| Long term debt | 489.67M | 342.86M | 324.00M | 290.00M | 232.22M |
| Inventory | - | - | -6.65M | - | - |
| Accounts payable | 12.35M | 11.54M | 10.07M | 14.25M | 13.62M |
| Accumulated other comprehensive income | -6.17M | 11.89M | 22.83M | 18.12M | 16.84M |
| Common stock total equity | - | - | - | - | 0.24M |
| Retained earnings total equity | - | - | - | - | 277.00M |
| Treasury stock | - | - | - | - | -135.97M |
| Non currrent assets other | 134.78M | 54.09M | 92.34M | 73.04M | 68.19M |
| Non current assets total | 1078.10M | 934.50M | 861.68M | 870.56M | 861.67M |
| Capital lease obligations | 38.67M | 42.00M | 49.88M | 56.09M | 64.45M |
| Long term debt total | - | - | - | - | 232.22M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.00M | -79.75M | -35.15M | -20.13M | -20.14M |
| Change to liabilities | - | - | - | -12.50M | -2.68M |
| Total cashflows from investing activities | -145.75M | -79.75M | -36.65M | -20.13M | -20.14M |
| Net borrowings | 153.31M | 33.69M | 34.00M | 57.22M | 29.50M |
| Total cash from financing activities | -45.03M | -111.64M | -98.33M | -74.11M | -44.41M |
| Change to operating activities | - | - | - | 35.30M | -5.31M |
| Net income | 105.04M | 116.63M | 62.48M | 75.55M | 62.99M |
| Change in cash | 2.60M | 9.76M | 0.32M | -8.95M | -46.40M |
| Begin period cash flow | 21.91M | 12.15M | 11.83M | 20.78M | 67.18M |
| End period cash flow | 24.51M | 21.91M | 12.15M | 11.83M | 20.78M |
| Total cash from operating activities | 193.39M | 201.32M | 135.26M | 85.40M | 17.99M |
| Depreciation | 32.43M | 25.30M | 24.94M | 27.36M | 25.98M |
| Other cashflows from investing activities | 0.15M | 0.15M | 0.15M | 2.66M | -9.27M |
| Dividends paid | - | - | 2.52M | - | - |
| Change to inventory | - | - | -4.56M | - | -44.13M |
| Change to account receivables | -14.92M | 0.63M | -64.10M | -25.85M | -39.84M |
| Sale purchase of stock | -166.72M | -145.09M | -133.29M | -128.19M | -74.72M |
| Other cashflows from financing activities | -33.60M | -0.23M | 0.97M | 309.44M | 235.80M |
| Change to netincome | - | - | - | 28.05M | 5.28M |
| Capital expenditures | 10.44M | 8.65M | 35.19M | 24.30M | 15.76M |
| Change receivables | - | - | - | - | -78.67M |
| Cash flows other operating | - | - | - | - | 4.30M |
| Exchange rate changes | - | - | - | - | 0.17M |
| Cash and cash equivalents changes | - | - | - | - | -46.40M |
| Change in working capital | -29.54M | 2.92M | -31.14M | -46.73M | -84.02M |
| Stock based compensation | 46.51M | 45.07M | 45.70M | 30.97M | 25.86M |
| Other non cash items | 28.07M | 8.79M | 39.47M | -20.54M | -25.30M |
| Free cash flow | 182.96M | 192.67M | 100.08M | 61.10M | 2.23M |
Sector: Industrials Industry: Consulting Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HURN Huron Consulting Group Inc |
-8.91 5.07% |
166.82 | 23.21 | 15.15 | 1.38 | 6.46 | 1.83 | 14.22 |
| EXPGF Experian PLC |
- -% |
42.30 | 26.59 | 19.34 | 4.43 | 6.44 | 4.99 | 14.01 |
| EXPGY Experian plc PK |
-1.27 3.03% |
40.58 | 26.45 | 19.30 | 4.41 | 6.43 | 4.99 | 14.01 |
| VRSK Verisk Analytics Inc |
-6.88 3.25% |
204.59 | 28.72 | 21.88 | 7.52 | 74.89 | 9.06 | 16.91 |
| EFX Equifax Inc |
-4.25 2.19% |
189.59 | 30.32 | 17.18 | 3.05 | 4.62 | 3.96 | 13.37 |
Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The company offers financial and operational performance improvement consulting services; digital services; spanning technology and analytic-related services, including enterprise health record, enterprise resource planning, enterprise performance management, customer relationship management, data management, artificial intelligence and automation, technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. It also provides research-focused consulting and managed services, as well as Huron Research product suite, a software suite designed to facilitate and improve research administration service delivery and compliance. In addition, the company offers software products, financial capital advisory services, regulatory compliance and risk management consulting, and Commercial consulting. The company serves healthcare, education, financial services, industrials and manufacturing, energy and utilities, public sector, and other commercial industries. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
550 West Van Buren Street, Chicago, IL, United States, 60607
312 583 8700
9248
| Name | Title | Year Born |
|---|---|---|
| Mr. James H. Roth M.B.A. | CEO & Director | 1958 |
| Mr. C. Mark Hussey C.F.A., C.M.A., CPA, M.B.A. | Pres | 1961 |
| Mr. John D. Kelly CPA, M.S. | Exec. VP, CFO & Treasurer | 1977 |
| Mr. Ernest W. Torain Jr., Esq. | Exec. VP, Gen. Counsel & Corp. Sec. | 1966 |
| Mr. J. Ronald Dail | Chief Operating Officer | NA |
| Mr. Sean Freeburger | Chief Information Officer | NA |
| Allie Bovis | PR Mang. | NA |
| Elizabeth Entinghe | Corp. VP of Corp. Devel. & Chief of Staff | NA |
| Sarah McHugh | Corp. VP & Chief Marketing Officer | NA |
| Ms. Kristen Bruner | Chief HR Officer & Corp. VP | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.